Hypertension · AI primary care

Primary care that reads your home BP trend the way a cardiologist would.

Nearly half of U.S. adults have hypertension and most are not at goal¹. Clara auto-syncs your chart and reads every home reading against your full medication list in seconds.

Get started How it works

My home cuff averages 146/93 mornings and 138/88 evenings for two weeks. Is this really hypertension?

Clara

Your 7-day home average is 144/92 — stage 2 by ACC/AHA, and the morning surge rules out white-coat. I'd start lisinopril 10 mg daily with a potassium and creatinine recheck at 2–4 weeks. Sending to our physician. Basic metabolic panel drafted at Quest. I'll watch for the results and flag any change in potassium or creatinine.

How it works

From a first reading to a controlled BP, in days, not three months.

Connect your chart, log your readings

Clara auto-syncs your records from 150,000+ doctors' offices, hospitals, clinics, labs, and wearable devices. Home cuff readings and wearable heart-rate data pool into one running view. Free.

Clara reads every trend

Clara reads your 7-day home average against your full medication list, allergies, and lab history, then drafts a plan: first-line medication, baseline labs, a target BP. A licensed physician reviews and signs off.

Titration on a clock

If your home BP is not at goal in 4 weeks, Clara flags it and drafts a dose step-up or an add-on agent against your full chart. You do not wait a quarter to adjust.

Your home cuff reads a pattern. The annual visit reads one moment.

Get startedFree to connect your records. No credit card.

Treatments

First-line medications, chosen from your data, not a template.

Rx · ACE inhibitor

Lisinopril

Once-daily ACE inhibitor. First-line for hypertension, and commonly used when there is concurrent diabetes, heart failure, or CKD. Clara monitors potassium and creatinine after starts and dose changes.

11%

Lower 6-week mortality vs. control in post-MI patients in GISSI-3³

Rx · Calcium channel blocker

Amlodipine

Once-daily dihydropyridine CCB. Effective across ages, often first-line for Black adults and older adults per ACC/AHA guidance. Well tolerated; dose-related peripheral edema is the main side effect.

~13/7 mmHg

Placebo-corrected supine BP reduction in pooled placebo-controlled trials⁴

Rx · ARB

Losartan

Angiotensin receptor blocker. The usual move when an ACE inhibitor causes cough. Indicated for hypertension, diabetic nephropathy in type 2 diabetes, and stroke risk reduction in hypertension with left ventricular hypertrophy⁵.

13%

Relative reduction in the LIFE primary composite vs. atenolol⁶

Rx · Thiazide diuretic

Hydrochlorothiazide (HCTZ)

Low-dose thiazide, frequently combined with an ACE inhibitor, ARB, or CCB for additive BP lowering. Clara watches potassium, sodium, and uric acid on labs.

Often combined for add-on control

Supportive · Lifestyle

DASH, sodium, sleep, weight

For stage 1 hypertension without high CV risk, lifestyle is first-line alongside or before medication. Clara builds a DASH-style plan, watches your sodium intake if you log meals, and cross-checks it against your home BP trend.

Tracked

Integrated with wearables and home cuff

Rx · Combinations

Two- and three-drug regimens

Most patients with stage 2 hypertension need more than one agent to reach goal. Clara flags when an add-on is warranted and drafts the order against your full chart. Lisinopril + HCTZ, losartan + HCTZ, and amlodipine + an ACE/ARB are common pairings.

Dose step-ups as needed

Why Clara

Hypertension care that does not end when the visit does.

	Clara	GoodRx Care	Circle Medical	Your doctor
24/7 AI clinical chat with full-chart reasoning	Unlimited	Per-visit only	Visit-based	✗
Home BP + wearable interpretation		✗	Visit-based	Depends on practice
Cost to start	Free (connect records + chat)	$49 per hypertension refill visit	$179 first visit self-pay	$150+ copay
Paid plans	$25/mo membership, HSA/FSA eligible	No membership, $49/visit ($19 w/ GoodRx Gold)	No membership, $120 follow-up self-pay	Per-visit copay
Prescription fills	FDA-approved generic, may be covered by your insurance	Sent to your pharmacy	Sent to your pharmacy	Sent to your pharmacy
Lab orders (potassium, creatinine, lipids)	Included	Extra	Ordered at visit, processed at Quest/Labcorp	Copay applies
Full primary care in one membership		Single-visit refill

Two weeks of home BP beats one office reading every time.

Get startedHSA/FSA eligible. Licensed in all 50 states.

The AI difference

Blood pressure is a trend. A 15-minute visit sees a snapshot.

Can your old doctor read every home BP reading, every Oura resting-heart-rate trend, and every potassium value you have ever had drawn, each time they see you? Clara can.

Pattern recognition across thousands of readings

Clara averages your home cuff readings over any window, cross-correlates them against wearable resting heart rate and sleep, and flags morning surges, masked hypertension, and white-coat patterns a single office reading cannot catch.

Interaction matrix, every time

Before recommending any BP drug, Clara runs it against every medication, allergy, and lab value in your chart — NSAIDs elevating your pressure, potassium-sparing risks, pregnancy contraindications. In seconds.

Titration when the number says to, not the calendar

If your 7-day home average is not at goal at week 4, Clara drafts the next step against your full chart. No waiting for the next 90-day follow-up to find out you are still above target.

Continuous blood pressure context, not a single number at the annual visit.

Get startedStart free. Membership from $25/month, HSA/FSA eligible.

Common questions

Hypertension questions patients ask.

How is Clara different from my regular doctor?

Your doctor sees a single in-office reading every three to six months. Clara reads every home cuff reading, every wearable heart-rate value, and every past lab in your chart on every interaction, and answers at 2am if your morning reading is abnormal. It is a category of work a 15-minute visit physically cannot do.

What blood pressure counts as hypertension?

The 2017 ACC/AHA guideline defines stage 1 as systolic 130 to 139 mmHg or diastolic 80 to 89 mmHg, and stage 2 as ≥140/90 mmHg, based on the average of two or more readings on two or more occasions². Clara uses those thresholds and applies your full clinical picture before recommending treatment.

What BP target does Clara aim for?

For most adults, the ACC/AHA goal is <130/80 mmHg. SPRINT showed that in high-risk adults (excluding diabetes and prior stroke), targeting systolic <120 mmHg reduced major cardiovascular events and all-cause mortality compared with a target of <140 mmHg⁷. Your target is individualized based on age, diabetes, CKD, and other conditions in your chart.

Will Clara order labs before starting a medication?

For ACE inhibitors, ARBs, and thiazides, a baseline basic metabolic panel (including potassium and creatinine) is standard. Clara drafts the order as part of the plan. Follow-up labs after starts and dose changes are handled the same way. Ad-hoc lab orders may be covered by your insurance at Labcorp or Quest.

Is Clara a real medical practice?

Yes. Clara is licensed in all 50 states and operates through affiliated professional corporations. A licensed physician reviews and signs off on every diagnosis, prescription, and lab order Clara's AI drafts. The AI runs intake, monitoring, and follow-up; the clinical sign-off happens at the end.

What does Clara cost, and can I use insurance?

Connecting your records and chatting with Clara is free. Paid plans start at $25/month for medical advice, prescriptions, and lab orders. All plans are HSA/FSA eligible. Clara's membership itself is cash-pay and is not billed through insurance. Prescriptions Clara writes go to your pharmacy and may be covered by your insurance, and ad-hoc lab orders at Labcorp or Quest may be covered by your insurance, depending on your plan.

Can I use Clara for other health issues too?

Yes. One membership covers full primary care, not just hypertension. It is common for hypertension patients to also track high cholesterol, type 2 diabetes, thyroid, and sleep. Clara runs preventive care on a clock and watches for the next-due A1C, ApoB, DEXA, or colonoscopy against guideline cadence.

What if I need a specialist or in-person care?

If a physical exam, imaging, or in-person procedure is needed (for example, suspected secondary hypertension, refractory BP, or an echocardiogram), Clara refers you to an in-person provider. Clara is the best fit for primary-care-level hypertension management and continuous monitoring.

Care that reads every reading, not just the ones at the office.

Start free. Connect your records. See what a full-chart plan looks like when AI is the one reading the trend.

Get started

ACE inhibitors (including lisinopril) and ARBs (including losartan) can cause fetal harm and are contraindicated in pregnancy; discontinue as soon as pregnancy is detected. Other labeled risks include symptomatic hypotension, acute kidney injury, hyperkalemia, and angioedema. Amlodipine's most common dose-related adverse reactions include peripheral edema, headache, and dizziness. Thiazide diuretics (including hydrochlorothiazide) can cause hypokalemia, hyponatremia, and elevated uric acid. For important safety information about the medications referenced on this page, see the FDA Medication Guides and prescribing information: Lisinopril, Amlodipine, Losartan, Hydrochlorothiazide.

¹Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017–2018. NCHS Data Brief, no 364. Hyattsville, MD: National Center for Health Statistics, 2020. Age-adjusted prevalence 45.4% among U.S. adults aged 18 and over, defined as ≥130/80 mmHg or taking antihypertensive medication. View NCHS Data Brief.

²Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127–e248. Stage 1: systolic 130–139 or diastolic 80–89 mmHg; Stage 2: ≥140/90 mmHg; goal <130/80 mmHg for most adults. View on PubMed.

³Lisinopril tablets USP: FDA-approved prescribing information. Acute myocardial infarction mortality data sourced from Section 14.3 (Clinical Studies, GISSI-3): 11% lower 6-week mortality risk in patients randomized to lisinopril (6.4% vs. 7.2%, p=0.04; n=9,646 vs. 9,672). View DailyMed label.

⁴Amlodipine besylate tablets: FDA-approved prescribing information, Section 12.2 (Pharmacodynamics). Placebo-corrected BP reductions at 24 hours post-dose, pooled across 15 double-blind placebo-controlled trials: approximately 12/6 mmHg standing and 13/7 mmHg supine in patients with mild to moderate hypertension. View DailyMed label.

⁵Cozaar (losartan potassium) tablets: FDA-approved prescribing information, Section 1 (Indications and Usage): hypertension, diabetic nephropathy in type 2 diabetes with a history of hypertension, and reduction of stroke risk in hypertension with left ventricular hypertrophy. View DailyMed label.

⁶Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995–1003. Primary composite (CV death, MI, stroke): hazard ratio 0.87 (95% CI 0.77–0.98, p=0.021) in favor of losartan. View on PubMed.

⁷SPRINT Research Group; Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–2116. Primary composite (MI, other ACS, stroke, HF, CV death): hazard ratio 0.75 (95% CI 0.64–0.89) for intensive (<120 mmHg) vs. standard (<140 mmHg). All-cause mortality: hazard ratio 0.73 (95% CI 0.60–0.90). View on PubMed.